KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Common Equity (2016 - 2025)

Historic Common Equity for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $7.3 billion.

  • Quest Diagnostics' Common Equity rose 663.65% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 663.65%. This contributed to the annual value of $6.8 billion for FY2024, which is 742.67% up from last year.
  • As of Q3 2025, Quest Diagnostics' Common Equity stood at $7.3 billion, which was up 663.65% from $7.3 billion recorded in Q2 2025.
  • Quest Diagnostics' Common Equity's 5-year high stood at $7.3 billion during Q3 2025, with a 5-year trough of $5.9 billion in Q4 2022.
  • Over the past 5 years, Quest Diagnostics' median Common Equity value was $6.5 billion (recorded in 2023), while the average stood at $6.5 billion.
  • In the last 5 years, Quest Diagnostics' Common Equity soared by 1906.01% in 2021 and then tumbled by 853.0% in 2022.
  • Quest Diagnostics' Common Equity (Quarter) stood at $6.5 billion in 2021, then decreased by 8.53% to $5.9 billion in 2022, then rose by 6.95% to $6.3 billion in 2023, then grew by 7.43% to $6.8 billion in 2024, then grew by 7.07% to $7.3 billion in 2025.
  • Its Common Equity stands at $7.3 billion for Q3 2025, versus $7.3 billion for Q2 2025 and $7.0 billion for Q1 2025.